-
An Innovative Medical Device Company
Cardiogenesis is innovating tools for the treatment of chronic cardiac ischemia. Located in Irvine, California, Cardiogenesis is the clinical and market leader in Transmyocardial Revascularization and is leading the way in advanced combination angiogenic therapies for the treatment of diffuse coronary artery disease in medical centers in Europe and throughout the world.
-
Clinical Data
Cardiogenesis has extensive clinical data on the efficacy of stand-alone laser channeling (without stem cells). The preliminary clinical results of the combination of laser tissue stimulation with direct injection of bone marrow cells, recently published in European Journal of Thoracic Surgery, have demonstrated the feasibility with favorable initial results.
If you are a European medical professional and want to learn more about our PHOENIX Delivery System visit our Technology Page